Advertisement

AIDS and Behavior

, Volume 23, Issue 7, pp 1964–1973 | Cite as

Experiences of Anticipated and Enacted Pre-exposure Prophylaxis (PrEP) Stigma Among Latino MSM in Los Angeles

  • Ronald A. BrooksEmail author
  • Amanda Landrian
  • Omar Nieto
  • Anne Fehrenbacher
Original Paper

Abstract

Latino men who have sex with men (MSM) are a group critically affected by HIV. Pre-exposure Prophylaxis (PrEP) is a biomedical prevention strategy that can help reduce new infections in this population. However, PrEP use may expose users to experiences of PrEP-related stigma. In-depth interviews conducted with Latino MSM PrEP users (N = 29) were analyzed using thematic analysis to explore experiences of PrEP stigma. Six themes emerged related to anticipated and enacted PrEP stigma: (1) Perception that PrEP users engage in risky sexual behaviors; (2) PrEP-induced conflict in relationships; (3) Perception that PrEP users are HIV-positive; (4) Generational differences in attitudes toward HIV prevention; (5) Experiences of discomfort, judgment, or homophobia from medical providers; and (6) Gay stigma related to PrEP disclosure to family. Manifestations of stigma included disapproving judgment, negative labeling, rejection, and devaluing individuals. The social consequences associated with using PrEP may deter uptake and persistence among Latino MSM.

Keywords

Latino Hispanic Men who have sex with men Pre-exposure prophylaxis Stigma 

Notes

Acknowledgements

The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institutes of Health. We thank the participants for graciously sharing their views and experiences for this study. This work was supported by the National Institute of Mental Health [Grant Nos: R21MH107339 and T32MH109205] and by the UCLA Center for HIV Identification, Prevention, and Treatment (CHIPTS) [Grant P30MH058107].

Compliance with Ethical Standards

Conflict of interest

All authors declare having no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Centers for Disease Control and Prevention. Diagnosis of HIV Infection in the United States and Dependent Areas, 2016. 2017.Google Scholar
  2. 2.
    Center for Disease Control and Prevention. Lifetime risk of HIV Diagnosis. 2016.Google Scholar
  3. 3.
    Centers for Disease Control and Prevention. CDC Fact Sheet: HIV incidence—estimated annual infections in the U.S., 2008-2014 Overall and by Transmission. 2017.Google Scholar
  4. 4.
    Division of HIV and STD Programs, Los Angeles County Department of Public Health. 2014 Annual HIV/STD Surveillance Report. 2016.Google Scholar
  5. 5.
    Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.CrossRefGoogle Scholar
  6. 6.
    Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410.CrossRefGoogle Scholar
  7. 7.
    Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423–34.CrossRefGoogle Scholar
  8. 8.
    Centers for Disease Control and Prevention. Preexposure prophylaxis for the prevention of HIV infection in the United States—2014 clinical practice guideline. 2014.Google Scholar
  9. 9.
    Centers for Disease Control and Prevention. HIV prevention pill not reaching most Americans who could benefit—especially people of color, presented at the 2018 Conference on Retroviruses and Opportunistic Infections, Boston, MA: National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Newsroom. 2018.Google Scholar
  10. 10.
    Holloway IW, Dougherty R, Gildner J, et al. Brief report: PrEP uptake, adherence, and discontinuation among california YMSM using geosocial networking applications. J Acquir Immune Defic Syndr. 2017;74(1):15–20.CrossRefGoogle Scholar
  11. 11.
    Okafor CN, Gorbach PM, Ragsdale A, Quinn B, Shoptaw S. Correlates of preexposure prophylaxis (PrEP) use among men who have sex with men (MSM) in Los Angeles, California. J Urban Health. 2017;94(5):710–5.CrossRefGoogle Scholar
  12. 12.
    Brooks RA, Landovitz RJ, Regan R, Lee SJ, Allen VC Jr. Perceptions of and intentions to adopt HIV pre-exposure prophylaxis among black men who have sex with men in Los Angeles. Int J STD AIDS. 2015;26(14):1040–8.CrossRefGoogle Scholar
  13. 13.
    Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDs. 2013;27(4):248–54.CrossRefGoogle Scholar
  14. 14.
    García M, Harris AL. PrEP awareness and decision-making for Latino MSM in San Antonio, Texas. PLoS ONE. 2017;12(9):e0184014.CrossRefGoogle Scholar
  15. 15.
    Lelutiu-Weinberger C, Golub SA. Enhancing PrEP access for black and Latino men who have sex with men. J Acquir Immune Defic Syndr. 2016;73(5):547–55.CrossRefGoogle Scholar
  16. 16.
    Brooks RA, Allen VC Jr, Regan R, Mutchler MG, Cervantes-Tadeo R, Lee SJ. HIV/AIDS conspiracy beliefs and intention to adopt preexposure prophylaxis among black men who have sex with men in Los Angeles. Int J STD AIDS. 2018;29(4):375–81.CrossRefGoogle Scholar
  17. 17.
    Eaton LA, Kalichman SC, Price D, Finneran S, Allen A, Maksut J. Stigma and conspiracy beliefs related to pre-exposure prophylaxis (PrEP) and interest in using PrEP among black and white men and transgender women who have sex with men. AIDS Behav. 2017;21(5):1236–46.CrossRefGoogle Scholar
  18. 18.
    Haire BG. Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence—a narrative review. HIV/AIDS (Auckland, NZ). 2015;7:241.Google Scholar
  19. 19.
    Schnarrs PW, Gordon D, Martin-Valenzuela R, et al. Perceived social norms about oral PrEP use: Differences Between African-American, Latino and White gay, bisexual and other men who have sex with men in Texas. AIDS Behav. 2018;30:1–5.Google Scholar
  20. 20.
    Goffman E. Stigma: notes on the management of spoiled identity. New York: Simon and Schuster; 2009.Google Scholar
  21. 21.
    Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav. 2009;13(6):1160.CrossRefGoogle Scholar
  22. 22.
    Brooks RA, Nieto O, Landrian A, Donohoe TJ. Persistent stigmatizing and negative perceptions of pre-exposure prophylaxis (PrEP) users: implications for PrEP adoption among Latino men who have sex with men. AIDS Care. 2018;19:1–9.Google Scholar
  23. 23.
    Mimiaga MJ, Closson EF, Kothary V, Mitty JA. Sexual partnerships and considerations for HIV antiretroviral pre-exposure prophylaxis utilization among high-risk substance using men who have sex with men. Arch Sex Behav. 2014;43(1):99–106.CrossRefGoogle Scholar
  24. 24.
    Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.CrossRefGoogle Scholar
  25. 25.
    Collins SP, McMahan VM, Stekler JD. The impact of HIV Pre-exposure Prophylaxis (PrEP) use on the sexual health of men who have sex with men: a qualitative study in Seattle, WA. Int J Sex Health. 2017;29(1):55–68.CrossRefGoogle Scholar
  26. 26.
    Dubov A, Galbo P Jr, Altice FL, Fraenkel L. Stigma and shame experiences by MSM who take PrEP for HIV prevention: a qualitative study. Am J Men’s Health. 2015;12(6):1849–54.Google Scholar
  27. 27.
    Franks J, Hirsch-Moverman Y, Loquere AS, et al. Sex, PrEP, and stigma: experiences with HIV pre-exposure prophylaxis among New York City MSM participating in the HPTN 067/ADAPT Study. AIDS Behav. 2018;22(4):1139–49.CrossRefGoogle Scholar
  28. 28.
    Darrow WW, Montanea JE, Gladwin H. AIDS-related stigma among Black and Hispanic young adults. AIDS Behav. 2009;13(6):1178.CrossRefGoogle Scholar
  29. 29.
    Grieb SM, Shah H, Flores-Miller A, Zelaya C, Page KR. HIV-related stigma among Spanish-speaking Latinos in an emerging immigrant receiving city. J Immigr Minor Health. 2017;19(4):868–75.CrossRefGoogle Scholar
  30. 30.
    Wohl AR, Galvan FH, Carlos JA, et al. A comparison of MSM stigma, HIV stigma and depression in HIV-positive Latino and African American men who have sex with men (MSM). AIDS Behav. 2013;17(4):1454–64.CrossRefGoogle Scholar
  31. 31.
    Bernstein KT, Liu KL, Begier EM, Koblin B, Karpati A, Murrill C. Same-sex attraction disclosure to health care providers among New York City men who have sex with men: implications for HIV testing approaches. Arch Intern Med. 2008;168(13):1458–64.CrossRefGoogle Scholar
  32. 32.
    Pathela P, Hajat A, Schillinger J, Blank S, Sell R, Mostashari F. Discordance between sexual behavior and self-reported sexual identity: a population-based survey of New York City men. Ann Intern Med. 2006;145(6):416–25.CrossRefGoogle Scholar
  33. 33.
    Petroll AE, Mosack KE. Physician awareness of sexual orientation and preventive health recommendations to men who have sex with men. J Sex Transm Dis. 2011;38(1):63.CrossRefGoogle Scholar
  34. 34.
    Rhodes SD, Hergenrather KC, Aronson RE, et al. Latino men who have sex with men and HIV in the rural south-eastern USA: findings from ethnographic in-depth interviews. Cult Health Sex. 2010;12(7):797–812.CrossRefGoogle Scholar
  35. 35.
    Gilead Sciences, Inc. Press Release: U.S. Food and Drug Administration Approves Expanded Indication for Truvada® (Emtricitabine and Tenofovir Disoproxil Fumarate) for Reducing the Risk of Acquiring HIV-1 in Adolescents. 2018.Google Scholar
  36. 36.
    Darling RB. Toward a model of changing disability identities: a proposed typology and research agenda. Disabil Soc. 2003;18(7):881–95.CrossRefGoogle Scholar
  37. 37.
    Herman NJ. Return to sender: reintegrative stigma-management strategies of ex-psychiatric patients. J Contemp Ethnogr. 1993;22(3):295–330.CrossRefGoogle Scholar
  38. 38.
    Siegel K, Lune H, Meyer IH. Stigma management among gay/bisexual men with HIV/AIDS. Qual Sociol. 1998;21(1):3–24.CrossRefGoogle Scholar
  39. 39.
    Calabrese SK, Underhill K. How stigma surrounding the use of HIV preexposure prophylaxis undermines prevention and pleasure: a call to destigmatize “truvada whores”. Am J Public Health. 2015;105(10):1960–4.CrossRefGoogle Scholar
  40. 40.
    Celum CL, Delany-Moretlwe S, McConnell M, Van Rooyen H, Bekker LG, Kurth A, Bukusi E, Desmond C, Morton J, Baeten JM. Rethinking HIV prevention to prepare for oral PrEP implementation for young African women. J Int AIDS Soc. 2015;18:20227.CrossRefGoogle Scholar
  41. 41.
    Golub SA. PrEP stigma: implicit and explicit drivers of disparity. Curr HIV/AIDS Rep. 2018;19:1–8.Google Scholar
  42. 42.
    Underhill K. Intimacy, condom use, and pre-exposure prophylaxis (PrEP) acceptability among men who have sex with men (MSM) in primary partnerships: a comment on Gamarel and Golub. Ann Behav Med. 2014;49(2):151–3.CrossRefGoogle Scholar
  43. 43.
    Feldman BJ, Fredericksen RJ, Crane PK, et al. Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. AIDS Behav. 2013;17(1):307–18.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Ronald A. Brooks
    • 1
    • 2
    • 5
    Email author
  • Amanda Landrian
    • 1
    • 3
  • Omar Nieto
    • 1
  • Anne Fehrenbacher
    • 1
    • 2
    • 4
  1. 1.Department of Family MedicineUniversity of CaliforniaLos AngelesUSA
  2. 2.Center for HIV Identification, Prevention, and Treatment Services (CHIPTS)University of CaliforniaLos AngelesUSA
  3. 3.Department of Community Health Sciences, Fielding School of Public HealthUniversity of CaliforniaLos AngelesUSA
  4. 4.Department of Psychiatry and Biobehavioral Sciences, Semel InstituteUniversity of CaliforniaLos AngelesUSA
  5. 5.Department of Family MedicineUCLALos AngelesUSA

Personalised recommendations